DermTech, Inc.
DMTK · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,010 | -$19,091 | -$19,164 | -$31,363 |
| Dep. & Amort. | $1,406 | $1,346 | $1,348 | $1,479 |
| Deferred Tax | $0 | -$4,804 | $0 | $7,355 |
| Stock-Based Comp. | $2,697 | $3,151 | $3,163 | $7,515 |
| Change in WC | -$1,108 | $2,066 | -$4,244 | -$672 |
| Other Non-Cash | -$104 | $4,625 | -$146 | -$7,515 |
| Operating Cash Flow | -$17,119 | -$12,707 | -$19,043 | -$23,201 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $163 | -$49 | -$259 |
| Net Acquisitions | $0 | -$12,080 | -$12,806 | -$13,317 |
| Inv. Purchases | $0 | -$20 | -$8,805 | -$9,087 |
| Inv. Sales/Matur. | $7,834 | $12,100 | $21,611 | $22,404 |
| Other Inv. Act. | $0 | $12,080 | $12,806 | $13,317 |
| Investing Cash Flow | $7,834 | $12,243 | $12,757 | $13,058 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $126 | $0 | $483 | $4,495 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $122 | -$24 | $726 | $4,461 |
| Financing Cash Flow | $122 | -$24 | $726 | $4,461 |
| Forex Effect | $0 | -$1 | $0 | $13,197 |
| Net Chg. in Cash | -$9,162 | -$489 | -$5,560 | -$5,682 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36,741 | $37,230 | $46,257 | $51,939 |
| End Cash | $27,579 | $36,741 | $40,697 | $46,257 |
| Free Cash Flow | -$17,119 | -$12,544 | -$19,092 | -$23,460 |